TrialBMC cancer2011

Phase II study of weekly paclitaxel and capecitabine in patients with metastatic or recurrent esophageal squamous cell carcinoma.

Tak Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.